1.
Canadian Medical Association. Journal
; 194(6):218, 2022.
Article
in English
| ProQuest Central | ID: covidwho-1695685
ABSTRACT
McDonald and Lee present several facts about nirmatrelvir-ritonavir. Ritonavir-boosted nirmatrelvir is a Health Canada-approved oral antiviral medication with activity against SARS-CoV-2 Treatment is indicated for adult (≥ 18 yr) outpatients with nonhypoxic COVID-19 who are at high risk of severe disease progression.